Di Nuzzo Private Wealth, Inc. Cytokinetics Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $634 Million
- Q3 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 15 shares of CYTK stock, worth $832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 8
87.5%
Holding current value
$832
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$814 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$635 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$452 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$417 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$363 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.22B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...